<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <p content-type="self-citation">
  <mixed-citation publication-type="journal" id="irv12697-cit-1001">
   <string-name>
    <surname>Khalaj‐Hedayati</surname>
    <given-names>A</given-names>
   </string-name>, 
   <string-name>
    <surname>Chua</surname>
    <given-names>CLL</given-names>
   </string-name>, 
   <string-name>
    <surname>Smooker</surname>
    <given-names>P</given-names>
   </string-name>, 
   <string-name>
    <surname>Lee</surname>
    <given-names>KW</given-names>
   </string-name>. 
   <article-title>Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement</article-title>. 
   <source xml:lang="en">Influenza Other Respi Viruses</source>. 
   <year>2020</year>;
   <volume>14</volume>:
   <fpage>92</fpage>–
   <lpage>101</lpage>. 
   <pub-id pub-id-type="doi">10.1111/irv.12697</pub-id>
  </mixed-citation>
 </p>
 <fn-group id="irv12697-ntgp-0001">
  <fn id="irv12697-note-0002">
   <p>The peer review history for this article is available at 
    <ext-link ext-link-type="uri" xlink:href="https://publons.com/publon/10.1111/irv.12697" xmlns:xlink="http://www.w3.org/1999/xlink">https://publons.com/publon/10.1111/irv.12697</ext-link>.
   </p>
  </fn>
 </fn-group>
</notes>
